Obesity Management Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Obesity</strong> <strong>Management</strong> <strong>Market</strong>: Global Industry Analysis<br />
and Opportunity Assessment 2017-2027<br />
May 2017<br />
Report Id : REP-GB-587<br />
Status : April-2017<br />
Category : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom<br />
research reports, and consulting services. We deliver a complete packaged solution, which<br />
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth<br />
insights, aerial view of the competitive framework, and future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC,<br />
ASEAN, and BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,<br />
Technology, Healthcare, and Retail.<br />
We have a global presence with delivery centers across India specializing in providing global<br />
research reports and country research reports. FMI is headquartered out of London, U.K., with a<br />
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning<br />
from every corner of the world to distill it to one thing – the perfect solution for our client.<br />
Research Capabilities<br />
Sector Coverage<br />
<br />
<br />
<br />
<br />
Customized Research<br />
Syndicated Research<br />
Investment Research<br />
Social Media Research<br />
<br />
<br />
<br />
<br />
Automotive and Transportation<br />
Electronics, Semiconductor, and ICT<br />
Retail and Consumer Products<br />
Industrial Automation and Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & Materials<br />
Food and Beverages<br />
Services and Utilities<br />
Energy, Mining, Oil, and Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
Research Methodology (1/2)<br />
Systematic Research Approach<br />
<strong>Market</strong> profiling<br />
Formulating discussion guide<br />
Developing list of respondents<br />
Data collection<br />
Data validation<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used to<br />
ascertain overall market size, top<br />
industry players, top products, industry<br />
associations, etc.<br />
PMR formulates a detailed discussion<br />
guide to conduct expert and industry<br />
interviews<br />
PMR develops a list of industry players<br />
(manufacturers), distributors, retailers<br />
and industry experts<br />
PMR conducts interviews with industry<br />
experts, industry players, distributors<br />
and retailers<br />
Data is validated by triangulation<br />
method, wherein secondary, primary<br />
and PMR analysis contribute to the final<br />
data<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Data<br />
Collection<br />
Data Filter<br />
& Analysis<br />
Identifying key opinion leaders<br />
Questionnaire design<br />
In-depth interviews<br />
Coverage across value chain<br />
<strong>Market</strong> participants<br />
Key strengths<br />
Product portfolio<br />
Mapping as per value chain<br />
Key focus segments<br />
A<br />
Primary<br />
Research<br />
C<br />
Company<br />
Analysis<br />
Research &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
Research<br />
<br />
<br />
<br />
<br />
<br />
<br />
Business<br />
Solution<br />
Key industry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
Products<br />
Conclusions<br />
Data analysis<br />
6<br />
Data is scrutinized using MS-Excel to<br />
obtain qualitative and quantitative<br />
insights about the industry<br />
Primary Research #<br />
Secondary Research #<br />
Paid Publications#<br />
Insights<br />
7<br />
PMR delivers industry insights and<br />
information in the required format<br />
(PDF)<br />
<br />
<br />
<br />
<br />
Linkedin<br />
Zoominfo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
Financial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltwater<br />
# includes sources of databases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
<strong>Obesity</strong> <strong>Management</strong> <strong>Market</strong><br />
High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial<br />
support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long<br />
gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes<br />
the expenditure significantly. Considering this scenario, manufacturers are being cautious while seeking<br />
better return on investments. In the long run, risks and limitations posed by the high development costs of<br />
obesity drugs are likely to impede the growth of the global obesity management market.<br />
Future <strong>Market</strong> Insights’ latest publication estimates that the global market for obesity management will<br />
showcase an average growth during the forecast period, 2017-2027. In this period, the market is estimated<br />
to grow from US$ 641.6 Mn in 2016 to US$ 1,078.9 by 2027-end, representing a value CAGR of 4.9%.<br />
Between 2017 and 2027, the global obesity management market is poised to witness an incremental $<br />
opportunity of over US$ 400 Mn.<br />
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-587<br />
In addition the high costs for developing obesity management drugs, the market is also expected to witness<br />
restraints from poor healthcare infrastructure in emerging markets. Stringent laws imposed upon drug<br />
manufacturers are also impacting the market’s growth. These laws are becoming more ambiguous, resulting<br />
into a slow-down in drug production. Moreover, studies revealing side effects of obesity management drugs<br />
are also causing major disturbance among regulatory bodies and manufacturers. GlaxoSmithKline plc.,<br />
VIVUS, Inc., Novo Nordisk A/S, Arena Pharmaceuticals, Inc., F. Hoffmann La Roche Ltd., and Orexigen,<br />
Therapeutics, Inc. are companies profiled in the report as leading participants of global obesity management<br />
market.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
<strong>Obesity</strong> <strong>Management</strong> <strong>Market</strong><br />
A regional analysis of global obesity management market, compiled in the report, projects that North<br />
America’s share on global revenues will surpass 33% towards the end of 2027. North America is anticipated<br />
to emerge as the largest market for obesity management in the world. Western Europe will also be at the<br />
forefront, bringing in an estimated US$ 222 Mn in revenues by 2027-end. Across different regions in the<br />
world, a majority of obesity management drugs will be distributed through hospital pharmacies. With more<br />
than 50% share in global revenues, hospital pharmacies will remain the largest distribution channel for<br />
obesity management drugs throughout the forecast period.<br />
Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-587<br />
In terms of surgery, the global demand for obesity management drugs is primarily concentrated towards<br />
treatments namely, gastric bypass surgery and gastric sleeve surgery. In addition to this, the report also<br />
projects that over one-third of global obesity management revenues will be accounted by global sales of<br />
liraglutide drugs. Demand for phentermine and topiramate drugs will also gain traction, registering revenue<br />
growth at 7% CAGR. Nonetheless, fastest revenue growth will be recorded by global sales of bupropion and<br />
naltrexone drugs, revenues from which will surpass US$ 100 Mn by end of 2027.<br />
Browse Full Report@ http://www.futuremarketinsights.com/reports/obesity-management-market<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
Table of Content<br />
1. Executive Summary<br />
2. <strong>Market</strong> Introduction<br />
2.1. <strong>Market</strong> Definition<br />
2.2. <strong>Market</strong> Taxonomy<br />
3. Global <strong>Obesity</strong> <strong>Management</strong> <strong>Market</strong> Analysis Scenario<br />
3.1. <strong>Market</strong> Size (US$ Mn) and Forecast<br />
3.1.1. <strong>Market</strong> Size and Y-o-Y Growth<br />
3.1.2. Absolute $ Opportunity<br />
3.2. <strong>Market</strong> Overview<br />
4. <strong>Market</strong> Dynamics<br />
4.1. Macro-economic Factors<br />
4.2. Drivers<br />
4.2.1. Supply and Demand Side<br />
4.3. Restraints<br />
4.4. Opportunity<br />
4.5. Forecast Factors – Relevance and Impact<br />
4.6.Scenario Forecast<br />
4.7.Trends<br />
4.8.Regulations Scenario<br />
4.9.Drug Pipeline Assessment<br />
4.10.Epidemiology Analysis<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
6
Table of Content<br />
5. Global <strong>Obesity</strong> <strong>Management</strong> <strong>Market</strong> Analysis and Forecasts, By Drug Type<br />
5.1. Introduction<br />
5.2. Basis Point Share (BPS) Analysis By Drug Type<br />
5.3. Y-o-Y Growth Projections By Drug Type<br />
5.4. <strong>Market</strong> Value Forecast By Drug Type, 2017–2027<br />
5.4.1. Bupropion and Naltrexone<br />
5.4.2. Orlistat<br />
5.4.3. Lorcaserin<br />
5.4.4. Phentermine and Topiramate<br />
5.4.5. Liraglutide<br />
5.5. <strong>Market</strong> Attractiveness By Drug Type<br />
6. Global <strong>Obesity</strong> <strong>Management</strong> <strong>Market</strong> Analysis and Forecasts, By Surgery Type<br />
6.1. Introduction<br />
6.2. Basis Point Share (BPS) Analysis By Surgery Type<br />
6.3. Y-o-Y Growth Projections By Surgery Type<br />
6.4. <strong>Market</strong> Value Forecast By Surgery Type, 2017–2027<br />
6.4.1. Gastric Bypass Surgery<br />
6.4.2. Adjustable Gastric Banding Surgery<br />
6.4.3. Gastric Sleeve Surgery<br />
6.4.4. Duodenal Switch Surgery<br />
6.4.5. Others<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
7
Table of Content<br />
7. Global <strong>Obesity</strong> <strong>Management</strong> <strong>Market</strong> Analysis and Forecasts, By Distribution Channel<br />
7.1. Introduction<br />
7.2. Basis Point Share (BPS) Analysis By Distribution Channel<br />
7.3. Y-o-Y Growth Projections By Distribution Channel<br />
7.4. <strong>Market</strong> Value Forecast By Distribution Channel, 2017–2027<br />
7.4.1. Hospitals Pharmacies<br />
7.4.2. Retail Pharmacies<br />
7.4.3. E- Commerce<br />
7.5. <strong>Market</strong> Attractiveness By Distribution Channel<br />
8. Global <strong>Obesity</strong> <strong>Management</strong> <strong>Market</strong> Analysis and Forecasts, By Region<br />
8.1. Basis Point Share (BPS) Analysis By Region<br />
8.2. Y-o-Y Growth Projections By Region<br />
8.3. <strong>Market</strong> Value Forecast By Region<br />
8.3.1. North America<br />
8.3.2. Latin America<br />
8.3.3. Western Europe<br />
8.3.4. Eastern Europe<br />
8.3.5. APEJ<br />
8.3.6. Japan<br />
8.3.7. MEA<br />
8.4. <strong>Market</strong> Attractiveness By Region<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
8
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For media queries, contact the press office at<br />
press@futuremarketinsights.com<br />
For other queries contact:<br />
Hari. T (Sr. Manager - Global Business Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consulting Private Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
9
Change language